Gilead Sciences, Inc. (GILD) is around the top of the Drug Manufacturers - General industry according to InvestorsObserver. GILD received an overall rating of 61, which means that it scores higher than 61 percent of all stocks. Gilead Sciences, Inc. also achieved a score of 75 in the Drug Manufacturers - General industry, putting it above 75 percent of Drug Manufacturers - General stocks. Drug Manufacturers - General is ranked 83 out of the 148 industries.
GILD has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on GILD!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 61 means the stock is more attractive than 61 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Gilead Sciences, Inc. Stock Today?
Gilead Sciences, Inc. (GILD) stock is trading at $62.82 as of 1:05 PM on Friday, Sep 23, a loss of -$0.96, or -1.5% from the previous closing price of $63.77. The stock has traded between $62.61 and $63.79 so far today. Volume today is below average. So far 3,051,579 shares have traded compared to average volume of 7,376,897 shares.
Click Here to get the full Stock Report for Gilead Sciences, Inc. stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
